Prenetics Global (PRE) Research & Development (2021 - 2026)

Prenetics Global has disclosed Research & Development across 6 years of filings, most recently posting -$1.4 million for Q1 2026.

• In Q1 2026, Research & Development rose 28.1% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$4.6 million (up 47.83% YoY), while the FY2025 annual figure was $5.1 million, down 43.3% from the prior year.
• Research & Development declined to -$1.4 million in Q1 2026, from -$743000.0 in the prior quarter.
• Over the last five years, Research & Development for PRE reached as high as -$743000.0 in Q4 2025 and fell as low as -$4.0 million in Q3 2023.
• The 5-year median for Research & Development is -$2.1 million (2024), against an average of -$2.2 million.
• Annual changes were most pronounced in 2022 — Research & Development surged 73.2% — and 2023, when it plunged 402.64%.
• A 5-year view of Research & Development shows it stood at -$1.5 million in 2022, then slumped by 76.79% to -$2.6 million in 2023, then rose by 18.5% to -$2.1 million in 2024, then soared by 64.75% to -$743000.0 in 2025, then slumped by 94.21% to -$1.4 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered -$1.4 million, -$743000.0, and -$1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.